Financials data is unavailable for this security.
View more
Year on year Aarti Drugs Ltd had revenues fall -6.90% from 27.16bn to 25.29bn, though the company grew net income 3.07% from 1.66bn to 1.71bn.
Gross margin | 34.32% |
---|---|
Net profit margin | 6.48% |
Operating margin | 10.12% |
Return on assets | -- |
---|---|
Return on equity | -- |
Return on investment | -- |
More ▼
Cash flow in INRView more
In 2024, cash reserves at Aarti Drugs Ltd fell by 7.61m. However, the company earned 3.59bn from its operations for a Cash Flow Margin of 14.19%. In addition the company used 2.24bn on investing activities and also paid 1.36bn in financing cash flows.
Cash flow per share | 22.77 |
---|---|
Price/Cash flow per share | 22.80 |
Book value per share | -- |
---|---|
Tangible book value per share | -- |
More ▼
Balance sheet in INRView more
Current ratio | -- |
---|---|
Quick ratio | -- |
Total debt/total equity | -- |
---|---|
Total debt/total capital | -- |
More ▼
Growth rates in INR
Year on year, growth in earnings per share excluding extraordinary items increased 3.82%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
Div yield(5 year avg) | 0.26% |
---|---|
Div growth rate (5 year) | -- |
Payout ratio (TTM) | 5.86% |
EPS growth(5 years) | 14.40 |
---|---|
EPS (TTM) vs TTM 1 year ago | -11.87 |
More ▼